The company has announced the first 10 companies that will be resident at its South San Francisco Jlabs campus.
Johnson & Johnson Innovation, a corporate venturing subsidiary of US-based healthcare products manufacturer Johnson & Johnson, has unveiled a 30,000-square foot incubator that will house up to 50 startups.
The company has also revealed the initial 10 companies which will be resident at the Jlabs South San Francisco campus.
They are immuno-oncology company Ab Initio Biotherapeutics, clinical-stage biopharmaceutical startups Afferent Pharmaceuticals and Alkahest, biopharmaceuical company Applied Molecular Transport, biotechnology developer Audentes Therapeutics, Alzheimer’s disease-focused pharmaceutical companies Cortexyme and Driver BioEngineering,…
